Kewalramani Reshma

Vertex Pharmaceuticals Inc ยท CEO & President

Kewalramani Reshma is listed in public filings as director, officer: CEO & President. This Kewalramani Reshma insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Vertex Pharmaceuticals Inc (VRTX), and Ginkgo Bioworks Holdings, Inc. (DNA). Investors use Kewalramani Reshma's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Vertex Pharmaceuticals IncVRTX$53M106k sharesSellFeb 27, 2026$7.7M15.6k shares$495.38--
Vertex Pharmaceuticals IncVRTX$50M100k sharesSellFeb 27, 2026$3.0M6k shares$496.16--
Vertex Pharmaceuticals IncVRTX$60M121.6k sharesSellFeb 27, 2026$1.7M3.5k shares$494.33--
Vertex Pharmaceuticals IncVRTX$64M131.7k sharesSellFeb 27, 2026$1.6M3.3k shares$488.27--
Vertex Pharmaceuticals IncVRTX$63M128.5k sharesSellFeb 27, 2026$1.3M2.7k shares$490.54--
Vertex Pharmaceuticals IncVRTX$62M125.1k sharesSellFeb 27, 2026$1.2M2.5k shares$493.29--
Vertex Pharmaceuticals IncVRTX$66M135k sharesSellFeb 27, 2026$1.2M2.5k shares$487.13--
Vertex Pharmaceuticals IncVRTX$49M98.3k sharesSellFeb 27, 2026$857.2K1.7k shares$496.95--
Vertex Pharmaceuticals IncVRTX$63M127.6k sharesSellFeb 27, 2026$466.2K949 shares$491.30--
Vertex Pharmaceuticals IncVRTX$64M131.3k sharesSellFeb 27, 2026$225.1K460 shares$489.32--
Vertex Pharmaceuticals IncVRTX$66M137.9k sharesSellFeb 27, 2026$191.9K400 shares$479.75--
Vertex Pharmaceuticals IncVRTX$66M137.5k sharesSellFeb 27, 2026$115.9K240 shares$482.84--
Vertex Pharmaceuticals IncVRTX$66M137.8k sharesSellFeb 27, 2026$57.8K120 shares$481.50--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Vertex Pharmaceuticals IncVRTX$67M138.3k sharesGrant / ExerciseFeb 24, 2026$2.4M5k shares$485.11--
Vertex Pharmaceuticals IncVRTX$69M143.3k sharesGrant / ExerciseFeb 17, 2026$3.2M6.6k shares$483.75--
Vertex Pharmaceuticals IncVRTX--149.8k sharesGrant / ExerciseFeb 17, 2026Disclosure amount unavailable16.3k shares----
Vertex Pharmaceuticals IncVRTX$65M133.5k sharesGrant / ExerciseFeb 13, 2026$6.4M13k shares$487.76--
Vertex Pharmaceuticals IncVRTX$69M146.5k sharesGrant / ExerciseFeb 10, 2026$3.9M8.3k shares$468.41--
Vertex Pharmaceuticals IncVRTX--142.9k sharesGrant / ExerciseJan 22, 2026Disclosure amount unavailable27k shares----
Vertex Pharmaceuticals IncVRTX--154.8k sharesGrant / ExerciseJan 22, 2026Disclosure amount unavailable11.9k shares----
Vertex Pharmaceuticals IncVRTX$45M116k sharesBuyAug 6, 2025$2.2M5.7k shares$389.95--
Vertex Pharmaceuticals IncVRTX$43M110.3k sharesBuyAug 6, 2025$1.7M4.3k shares$389.08--
Vertex Pharmaceuticals IncVRTX$51M105.9k sharesGrant / ExerciseFeb 26, 2025$6.8M14.1k shares$479.61--
Vertex Pharmaceuticals IncVRTX$58M120k sharesGrant / ExerciseFeb 24, 2025$4.5M9.4k shares$483.28--
Vertex Pharmaceuticals IncVRTX$60M129.4k sharesGrant / ExerciseFeb 14, 2025$3.0M6.6k shares$463.46--
Vertex Pharmaceuticals IncVRTX--135.9k sharesGrant / ExerciseFeb 12, 2025Disclosure amount unavailable19k shares----
Ginkgo Bioworks Holdings, Inc.DNA--105.3k sharesGrant / ExerciseJun 12, 2024Disclosure amount unavailable105.3k shares----